Fingerprint
Dive into the research topics of 'A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel Angel Perales, Yi Bin Chen, Gabrielle Meyers, John F. DiPersio
Research output: Contribution to journal › Article › peer-review
61
Scopus
citations